Agios Pharmaceuticals | Ativo Circulante

Preço das Ações
26.53
Mudança Diária
-0.04 -0.15%
Mensal
-7.04%
Anual
-20.71%
Q1 Previsão
25.72




Ativo Circulante Alterar Data
AbbVie USD 28.54B 722M 2025-09
Agios Pharmaceuticals USD 1.03B 13.64M 2025-09
Alnylam Pharmaceuticals USD 3.95B 309.11M 2025-09
Amgen USD 27.88B 1.15B 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Astellas Pharma JPY 1.44T 72.43B 2025-12
AstraZeneca USD 29.94B 1B 2025-09
Bayer EUR 32.88B 873M 2025-09
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Eli Lilly USD 62.07B 12.22B 2025-09
Exelixis USD 1.4B 221.5M 2025-09
Gilead Sciences USD 18.84B 4.12B 2025-09
GlaxoSmithKline GBP 17.51B 332M 2025-12
Incyte USD 4.28B 634.19M 2025-09
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Merck USD 47.56B 10.49B 2025-09
Moderna USD 6.6B 427M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Vertex Pharmaceuticals USD 10.57B 141.7M 2025-09


Agios Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.